TargetMol

Nicardipine hydrochloride

Product Code:
 
TAR-T1215
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1215-500mg500mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1215-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1215-1g1g£109.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Nicardipine Hydrochloride is the hydrochloride salt form of nicardipine, a synthetic derivative of nitrophenyl-pyridine and potent calcium channel blocker, Nicardipine (Nifedipine Family) blocks calcium ions from certain cell walls and inhibits contraction of coronary and peripheral arteries, resulting in lowered oxygen requirements for heart muscle and decreased arterial contraction and spasm. It is used clinically as a cerebral and coronary vasodilator.
CAS:
54527-84-3
Formula:
C26H30ClN3O6
Molecular Weight:
515.99
Pathway:
Membrane transporter/Ion channel; Neuroscience; Metabolism; Autophagy; GPCR/G Protein
Purity:
0.9987
SMILES:
Cl.COC(=O)C1=C(C)NC(C)=C(C1c1cccc(c1)[N+]([O-])=O)C(=O)OCCN(C)Cc1ccccc1
Target:
Calcium Channel; Adrenergic Receptor; AChR; Autophagy

References

1. Harino S, et al. Invest Ophthalmol Vis Sci, 1992, 33(10), 2885-2890. 2. Amenta F, et al. J Hypertens Suppl, 1996, 14(3), S29-35. 3. Willis AL, et al. Arteriosclerosis, 1985, 5(3), 250-255. 4. Gasior M, et al. J Neural Transm, 1996, 103(7), 819-831.